EXTEND abro by prior dupi response

Published: 14 February 2022| Version 1 | DOI: 10.17632/swvbf7czm3.1
Contributor:
Gary Chan

Description

supplemental data for dupi switch manuscript

Files

Institutions

Pfizer Ltd

Categories

Clinical Trial

Licence